Skip to main content
Veterinary Medicines

Cefenidex CA/DEX 2 mg/ml + 1 mg/ml eye drops, solution for dogs and cats

Authorised
  • Dexamethasone sodium phosphate
  • Chloramphenicol

Product identification

Medicine name:
Cefenidex CA/DEX 2 mg/ml + 1 mg/ml eye drops, solution for dogs and cats
Cefenidex 2 mg/ml + 1 mg/ml colírio, solução para cães e gatos
Active substance:
  • Dexamethasone sodium phosphate
  • Chloramphenicol
Target species:
  • Dog
  • Cat
Route of administration:
  • Ocular use

Product details

Active substance and strength:
  • Dexamethasone sodium phosphate
    1.32
    milligram(s)
    /
    1.00
    millilitre(s)
  • Chloramphenicol
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Eye drops, solution
Withdrawal period by route of administration:
  • Ocular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS01CA01
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • (ID1) Colourless LDPE dropper container, and a white HDPE screw cap. Pack size:Cardboard box with 1x10 ml dropper container.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cp-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 1657/01/24RFVPT
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0343/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 18/09/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."